Cutaneous manifestations of parvovirus B19 infection;Manifestations cutanées de l'infection par le parvovirus B19

Revue Medicale de Liege

Volumn 62, Issue 7-8, 2007, Pages 492-495

  Blaise, G ^a   Nikkels, A F ^a,b   Pierard G E ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b St Josef Klinik   (Belgium)

Author keywords

Erythema infectiosum; Papulo purpuric gloves and socks syndrome; Parvovirus B19

Indexed keywords

CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; ERYTHEMA INFECTIOSUM; ERYTHEMA NODOSUM; GLOVE; HUMAN; LUPUS ERYTHEMATOSUS; PARVOVIRUS; PITYRIASIS LICHENOIDES; PURPURIC RASH; RASH; REVIEW; SCLERODERMA; SKIN MANIFESTATION; VASCULITIS; SKIN; VIROLOGY;

DIAGNOSIS, DIFFERENTIAL; ERYTHEMA INFECTIOSUM; HUMANS; PARVOVIRUS B19, HUMAN; SKIN;

EID: 35448962959     PISSN: 00353663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Cossart YE, Field AM, Cant B, Widdows D. - Parvovirus-like particules in human sera. Lancet, 1975, 1, 72-73.
2. Anderson MJ, Jones SE, Fisher-Hoch SP, et al. - Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet, 1983, 1, 1378.
3. Whitley RJ. - Parvovirus infection : chance and investigation. N Engl J Med, 1985, 313, 111-112.
4. Vanfaie J, Schwartz RA. - Parvovirus B19 infections. Int J Dermatol, 2004, 43, 747-749.
5. Kerr Jr, Mattey DL, Thomson W, et al. - Association of symptomatic acute human parvovirus B19 infection with human leucocyte antigen class I and II alleles. J Infect Dis, 2002, 186, 447-452.
6. Brown KE, Anderson SM, Young NS. - Erythrocyte P antigen : cellular receptor for B19 parvovirus. Science, 1993, 262, 114-117.
7. Moffatt S, Tanaka N, Tada K, et al. - Acytotoxic nonstructural protein NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol, 1996, 70, 8485-8491.
8. Blaeser F, Kelly M, Siegrist K, et al. - Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clinical Immunology, 2005, 117, 231-237.
9. Ozawa K, Kurtzmann GJ, Young N. - Replication of the B19 Parvovirus in human bone marrow cell cultures. Science, 1986, 233, 883-886.
10. Takahashi M, Ito M, Sakamoto F, et al. - Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions. J Cutan Pathol, 1995, 22, 168-172.
11. Aractingi S, Bakhos D, Flageul B, et al. - Immunohistochemical and virological study of skin in the papular-purpuric gloves and socks syndrome. Br J Dermatol, 1996, 135, 599-602.
12. Loukeris D, Serelis J, Aroni K, et al. - Simultaneous occurrence of pure red cell aplasia and papular-purpuric «gloves and socks» syndrome in parvovirus B-19 infection. J Eur Acad Dermatol Venereol, 2005, 19, 373-376.
13. Plummer FA, Hammond GW, Forward K, et al. - An erythema infectiosum-like illness caused by human parvovirus infection. N Engl J Med, 1985, 313, 74-79.
14. Labbé L, Mortureux P, Leauté-Labreze C, Taïeb A. - Parvovirose cutanée : syndrome «gants et chausettes». Ann Dermatol Venereol, 1994, 121, 553-556.
15. Harms M, Feldmann R, Saurat JH. - Papular-purpuric " gloves ans socks" syndrome. J Am Acad Dermatol, 1990, 23, 850-854.
16. Nesher G, Osborn T, Moore TL. - Parvovirus infection mimicking systemic lupus erythematosus. Arthritis Rheum, 1995, 24, 297-303.
17. Soloninka CA, Anderson Ma, Laskin CA. - Anti-DNA and anti-lymphocyte antibodies during acute infection with human parvovirus B19. J Rheumatol, 1989, 16, 777-781.
18. Naides SJ, Piette W, Veach L, Argenyi Z. - Human parvovirus B19-induced vesiculopustular skin eruption. Am J Med, 1988, 84, 968-972.
19. Tomasini D, Tomasini CF, Cerri A, et al. - Pityriasis lichenoides : a cytotoxic cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases. J Cutan Pathol, 2004, 31, 531-538.
20. Browers S, Warshaw EM. - Pityriasis lichenoides and its subtypes. J Am Acad Dermatol, 2006, 55,557-572.
21. Magro CM, Nuovo G, Ferri C, et al. - Parvoviral infection of endothelial cells and stromal fibroblasts : a possible pathogenetic role in scleroderma. J Cutan Pathol, 2004, 31, 43-50.
22. Poole BD, Zhou J, Grote A, et al. - Apoptosis of liver-derivated cells induced by parvovirus B19 nonstructural protein. J Virol, 2006, 80, 4114-4121.
23. Druschky K, Walloch J, Heckmann J, et al. - Chronic parvovirus B-19 meningoencephalitis with additional detection of Epstein-Barr virus DNA in the cerebrospinal fluid of an immunocompetent patient. J Neurovirol, 2000, 6, 418-422.
24. Severin MC, Levy Y, Shoenfeld Y. - Systemic lupus erythematosus and parvovirus B-19 : casual coincidence or causative culprit? Clin Rev Allergy Immunol, 2003, 25, 41-48.
25. Kurtzmann GJ, Cohen B, Meters P, et al. - Persistent B19 Parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukemia. Lancet, 1988, 2, 1159-1162.
26. Kurtzmann GJ, Ozaka K, Cohen B, et al. - Chronic bone marrow failure due to persistent B19 parvovirus infection. N Eng J Med, 1987, 317, 287-294.